ARTICLE | Management Tracks
Plus: New scientific leadership at WEHI and an update from the HIV+Hepatitis Policy Institute
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
December 7, 2024 12:47 AM UTC
PharmaEssentia Corp. (TPEx:6446) hired Joseph Horvat as global chief commercial officer. Horvat was general manager at the U.S. subsidiary of MorphoSys AG.
Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI) named Marnie Blewitt, James Murphy, Tony Papenfuss and Andrew Roberts deputy directors, all effective in January. Blewitt will be responsible for the institute’s structural biology, genetics and gene regulation, and ubiquitin signaling divisions; Murphy for immunology, infection and global health, and inflammation; Papenfuss for advanced technology and biology, bioinformatics/computational biology, and new medicines and diagnostics; and Roberts for ACRF cancer biology, blood cancer and personalized oncology…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654408/horvat-to-lead-commercial-at-pharmaessentia